Status:
COMPLETED
Costs, Quality of Life and Functional Outcomes in Veterans Treated for Multiple Sclerosis With Beta-Interferon l-B (Betaseron)
Lead Sponsor:
US Department of Veterans Affairs
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
Brief Summary
The treatment of multiple sclerosis was evolving in light of specific drug therapies to treat the disease, refinements and acceptance of imaging with MRI to diagnose and monitor the disease process, a...
Detailed Description
Background: The treatment of multiple sclerosis was evolving in light of specific drug therapies to treat the disease, refinements and acceptance of imaging with MRI to diagnose and monitor the disea...
Eligibility Criteria
Inclusion
- Veteran enrolled at participating hospitals who have MS and are receiving the drugs of interest.
Exclusion
- Non-veterans or veterans not meeting the inclusion criteria.
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2000
Estimated Enrollment :
124 Patients enrolled
Trial Details
Trial ID
NCT00439257
End Date
June 1 2000
Last Update
April 7 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Connecticut Healthcare System West Haven Campus, West Haven, CT
West Haven, Connecticut, United States, 06516